Yahoo
NasdaqGS - Delayed Quote USD

Arrowhead Pharmaceuticals, Inc. (ARWR)

58.16 +0.70 (+1.22%)
At close: November 6 at 4:00:01 PM EST
58.16 +0.01 (+0.02%)
After hours: November 6 at 4:00:43 PM EST
Trade ARWR on Coinbase

News headlines

Updated 24m ago
Powered by Yahoo Scout

Arrowhead Pharmaceuticals presented additional clinical data supporting plozasiran’s triglyceride control and potential reduction in acute pancreatitis events. The company also reported lower-cost refinancing and continued international expansion for Redemplo, while its early ARO-MAPT program provided clinical evidence for subcutaneous RNA interference delivery into the central nervous system.

Mobilize your Website
View Site in Mobile | Classic
Share by: